Home › Postural Orthostatic Tachycardia Syndrome › NCT05107635
Inappropriate Sinus Tachycardia Registry
A Multicenter Patient Registry for Outcomes of Inappropriate Sinus Tachycardia and Postural Orthostatic Tachycardia Syndrome Treatment
Who can join
Ages 18 to 100 · All sexes
Full eligibility criteria
Inclusion Criteria: 1. Subject is scheduled to undergo or has undergone a procedure to treat IST or POTS using one or more AtriCure devices. 2. Subject is willing to provide written informed consent (defined as legally effective, documented confirmation of a subject's voluntary agreement to participate in this Registry) or authorization per institution and geographical requirements Exclusion Criteria: 1. Subject is enrolled in a concurrent study that may impact treatment outcome of IST or POTS. 2. Subject with exclusion criteria required by FDA or local governance
About the study
The primary objective of this registry is to capture real-world safety and performance data on AtriCure devices used to ablate cardiac tissue when treating Inappropriate Sinus Tachycardia (IST) or Postural Tachycardia Syndrome (POTS). This is a retrospective and prospective, multicenter, US/OUS, observational data registry.
What is being tested
- AtriCure Commercially Available Devices (device)
Sponsor: AtriCure, Inc. · Participants: 500 · Started: Mar 1, 2022
Contact the study team
- Registry Specialist · Phone: 866-349-2342
Official record on ClinicalTrials.gov — NCT05107635
Locations in the U.S.
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.